In addition, Feng et al. revealed that the expression of FGL2 in breast cancer was also significantly decreased, and the expression of FGL2 was positively correlated with anti-tumor immune cells such as B cells, T cells, macrophages and DC in breast cancer 83. The gene discussed is FGL2; the disease is breast cancer.